Birgitta Hiddinga

Zoekresultaten

• 2022

  A phase 1 study in patients with advanced non-small cell lung cancer treated with stereotactic radiotherapy to the primary tumor combined with durvalumab and tremelimumab

  Kievit, H., Muntinghe-Wagenaar, M. B., Ubbels, F., Wijsman, R., Hijmering-Kappelle, L., Hiddinga, B., Groen, H. J. M., Kerstjens, H. A. M., van der Wekken, A. J. & Hiltermann, T. J. N., 1-jun.-2022, In: Journal of Clinical Oncology. 40, 16_suppl, blz. e21121-e21121 1 blz.

  Onderzoeksoutput › Academic
• 2021

  High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from a phase II multicenter study, POSITION20

  Zwierenga, F., van Veggel, B. A. M. H., Hendriks, L. E. L., Hiltermann, T. J. N., Hiddinga, B. I., Hijmering-Kappelle, L. B. M., Dingemans, A.-M. C., van der Leest, C., de langen, A. J., van den Heuvel, M. & van der Wekken, A. J., 2021, In: Annals of Oncology. 32, S5, blz. S966-S966 1 blz.

  Onderzoeksoutput › Academic
• 2019

  ctDNA a promising predictive marker for treatment with PD-1 inhibitors in KRAS mutated NSCLC after platinum based chemotherapy

  Hiltermann, T. J. N., Hijmering-Kappelle, L. B. M., Azpurua, M. L. A., van der Wekken, A. J., Hiddinga, B. L., Timens, W., Groen, H. J. M. & Schuuring, E., jul.-2019, In: Cancer Research. 79, 13, 2 blz.

  Onderzoeksoutput › Academic

• Modeling of drug-protein interactions to support clinical decision making for therapy-resistant EGFR or ALK-positive non-small cell lung carcinoma

  Santos, J. F. V. M. R., Hiddinga, B. I., van Kempen, L. C., ter Elst, A., Hijmering, L. B., Hiltermann, T. J., Schuuring, E., Groves, M. R., Groen, H. J. & van der Wekken, A. J., jul.-2019, In: Cancer Research. 79, 13, 2 blz.

  Onderzoeksoutput › Academic

• PD-L1 expression, CD8 cells and MHC-class-1 Beta-2-microglobulin expression in advanced non-small lung cancer

  Hijmering-Kappelle, L., Hiltermann, J., Hiddinga, B., van der Wekken, A., 't Hart, N., Groen, H. & Timens, W., jul.-2019, In: Cancer Research. 79, 13, 2 blz.

  Onderzoeksoutput › Academic